Dupilumab

Grey

Brand Name(s):Dupixent

Indication:Chronic rhinosinusitis with nasal polyposis; in patients for whom therapy with systemic corticosteroids and/or surgery did not provide adequate disease control

Rationale:2

Considered:Jan-20

Review Date:Jul-21

Comments: